Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FRAGMATIC - A Randomised Phase III Clinical Trial Investigating the Effect of FRAGMin Added to Standard Therapy In Patients With Lung Cancer

NCT00519805 is registered in ClinicalTrials.gov with Velindre NHS Trust as lead sponsor.

NCT NCT00519805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00519805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FRAGMATIC - A Randomised Phase III Clinical Trial Investigating the Effect of FRAGMin Added to Standard Therapy In Patients With Lung Cancer
Lead sponsor
Velindre NHS Trust
Phase
Phase 3
Overall status
Unknown status
Start date
August 31, 2007
Completion date
Not reported
Enrollment
2,200 (estimated)
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, thromboembolism